LOPRESOR

This brand name is authorized in Australia, Canada, Spain, Israel, Italy, Japan, Mexico, South Africa

Active ingredients

The drug LOPRESOR contains one active pharmaceutical ingredient (API):

1 Metoprolol UNII W5S57Y3A5L - METOPROLOL TARTRATE

Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation. Read about Metoprolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOPRESOR Tablet, Solution for injection	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB02	Metoprolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1324Q, 1325R
Country: CA	Health Products and Food Branch	Identifier(s): 00534560, 00658855
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 54503
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 556
Country: IT	Agenzia del Farmaco	Identifier(s): 023610013, 023610025
Country: JP	医薬品医療機器総合機構	Identifier(s): 2149010F1033, 2149010F2072, 2149010G1055
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 87525
Country: ZA	Health Products Regulatory Authority	Identifier(s): H/5.2/72, R/5.2/171, X/5.2/95